Basic View  |  Expanded View
William J. Sandborn, MD; Paul Rutgeerts, MD, PhD; Robert Enns, MD; Stephen B. Hanauer, MD; Jean-Frédéric Colombel, MD; Remo Panaccione, MD; Geert D'Haens, MD; Ju Li, PhD; Marie R. Rosenfeld, BA; Jeffrey D. Kent, MD; and Paul F. Pollack, MD
Topics: crohn's disease, neoadjuvant therapy, infliximab, adalimumab
Herbert Marini, MD; Letteria Minutoli, MD; Francesca Polito, PhD; Alessandra Bitto, MD; Domenica Altavilla, PhD; Marco Atteritano, MD; Agostino Gaudio, MD; Susanna Mazzaferro, MD; Alessia Frisina, MD; Nicola Frisina, MD; Carla Lubrano, MD; Michele Bonaiuto, MD; Rosario D'Anna, MD; Maria Letizia Cannata, MD; Francesco Corrado, MD; Elena Bianca Adamo, MD; Steven Wilson, PhD; and Francesco Squadrito, MD
Topics: phytoestrogen, genistein, postmenopause, bone metabolism
Peder A. Halvorsen, MD; Randi Selmer, PhD; and Ivar Sønbø Kristiansen, MD, PhD, MPH
Topics: myocardial infarction, hip fractures, fracture, norway
Robert G. Hart, MD; Lesly A. Pearce, MS; and Maria I. Aguilar, MD
Includes: CME
Topics: antiplatelet agents, warfarin, fibrinolytic agents, nonvalvular atrial fibrillation, ischemic stroke, cerebrovascular accident, ...
Eric Manheimer, MS; Klaus Linde, MD, PhD; Lixing Lao, PhD, LAc; Lex M. Bouter, PhD; and Brian M. Berman, MD
Topics: acupuncture therapy discipline, osteoarthritis, knee, acupuncture procedure
Paul S. Mueller, MD, MPH; Victor M. Montori, MD, MSc; Dirk Bassler, MD, MSc; Barbara A. Koenig, PhD; and Gordon H. Guyatt, MD, MSc
Topics: ethics
Topics: #
Topics: crohn's disease, infliximab, adalimumab
Harold C. Sox, MD, Editor
Topics: disease prevention
Harriette Gillian Christine Van Spall, MD
Topics: #
Topics: #
Thomas Bodenheimer, MD; Robert A. Berenson, MD; and Paul Rudolf, MD, JD
Topics: #
Topics: #
Topics: opioid analgesics, opioids, pain
Topics: tumor necrosis factors, crohn's disease
Topics: phytoestrogen, genistein, postmenopause
Topics: myocardial infarction, hip fractures, norway, internal medicine, preventive medicine
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.